Erythritol and xylitol differentially impact brain networks involved in appetite regulation in healthy volunteers.

Xylitol cholecystokinin erythritol fMRI low-calorie sweetener peptide tyrosine tyrosine resting cerebral blood flow resting-state functional connectivity

Journal

Nutritional neuroscience
ISSN: 1476-8305
Titre abrégé: Nutr Neurosci
Pays: England
ID NLM: 100892202

Informations de publication

Date de publication:
Nov 2022
Historique:
pubmed: 19 8 2021
medline: 1 11 2022
entrez: 18 8 2021
Statut: ppublish

Résumé

There is a growing consensus that sugar consumption should be reduced and the naturally occurring, low-calorie sweeteners xylitol and erythritol are gaining popularity as substitutes, but their effect on brain circuitry regulating appetite is unknown. The study's objective was to examine the effects of the two sweeteners on cerebral blood flow (rCBF) and resting functional connectivity in brain networks involved in appetite regulation, and test whether these effects are related to gut hormone release. The study was performed as a randomized, double-blind, placebo-controlled, cross-over trial. Twenty volunteers received intragastric (ig) loads of 50g xylitol, 75g erythritol, 75g glucose dissolved in 300mL tap water or 300mL tap water. Resting perfusion and blood oxygenation level-dependent data were acquired to assess rCBF and functional connectivity. Blood samples were collected for determination of CCK, PYY, insulin and glucose. We found: (i) xylitol, but not erythritol, increased rCBF in the hypothalamus, whereas glucose had the opposite effect; (ii) graph analysis of resting functional connectivity revealed a complex pattern of similarities and differences in brain network properties following xylitol, erythritol, and glucose; (iii) erythritol and xylitol induced a rise in CCK and PYY, (iv) erythritol had no and xylitol only minimal effects on glucose and insulin. Xylitol and erythritol have a unique combination of properties: no calories, virtually no effect on glucose and insulin while promoting the release of gut hormones, and impacting appetite-regulating neurocircuitry consisting of both similarities and differences with glucose.

Sections du résumé

BACKGROUND UNASSIGNED
There is a growing consensus that sugar consumption should be reduced and the naturally occurring, low-calorie sweeteners xylitol and erythritol are gaining popularity as substitutes, but their effect on brain circuitry regulating appetite is unknown.
AIM UNASSIGNED
The study's objective was to examine the effects of the two sweeteners on cerebral blood flow (rCBF) and resting functional connectivity in brain networks involved in appetite regulation, and test whether these effects are related to gut hormone release.
METHODS UNASSIGNED
The study was performed as a randomized, double-blind, placebo-controlled, cross-over trial. Twenty volunteers received intragastric (ig) loads of 50g xylitol, 75g erythritol, 75g glucose dissolved in 300mL tap water or 300mL tap water. Resting perfusion and blood oxygenation level-dependent data were acquired to assess rCBF and functional connectivity. Blood samples were collected for determination of CCK, PYY, insulin and glucose.
RESULTS UNASSIGNED
We found: (i) xylitol, but not erythritol, increased rCBF in the hypothalamus, whereas glucose had the opposite effect; (ii) graph analysis of resting functional connectivity revealed a complex pattern of similarities and differences in brain network properties following xylitol, erythritol, and glucose; (iii) erythritol and xylitol induced a rise in CCK and PYY, (iv) erythritol had no and xylitol only minimal effects on glucose and insulin.
CONCLUSION UNASSIGNED
Xylitol and erythritol have a unique combination of properties: no calories, virtually no effect on glucose and insulin while promoting the release of gut hormones, and impacting appetite-regulating neurocircuitry consisting of both similarities and differences with glucose.

Identifiants

pubmed: 34404339
doi: 10.1080/1028415X.2021.1965787
doi:

Substances chimiques

Xylitol VCQ006KQ1E
Erythritol RA96B954X6
Sweetening Agents 0
Glucose IY9XDZ35W2
Water 059QF0KO0R
Insulins 0

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2344-2358

Auteurs

Anne Christin Meyer-Gerspach (AC)

St. Clara Research Ltd at St. Clara Hospital, Basel, Switzerland.
Department of Medicine, University of Basel, Basel, Switzerland.

Jed O Wingrove (JO)

Centre for Obesity Research, University College London, London, UK.

Christoph Beglinger (C)

St. Clara Research Ltd at St. Clara Hospital, Basel, Switzerland.

Jens F Rehfeld (JF)

Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Carel W Le Roux (CW)

Diabetes Complications Research Centre, Conway Institute University College Dublin, Dublin, Ireland.

Ralph Peterli (R)

Department of Medicine, University of Basel, Basel, Switzerland.
Clarunis, Department of Visceral Surgery, University Centre for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital Basel, Basel, Switzerland.

Patrick Dupont (P)

Department of Neurosciences, Laboratory for Cognitive Neurology, KU Leuven, Leuven, Belgium.

Owen O'Daly (O)

Centre for Neuroimaging Sciences, King's College London's Institute of Psychiatry, Psychology and Neuroscience, London, UK.

Lukas Van Oudenhove (L)

Laboratory for Brain-Gut Axis Studies (LaBGAS), Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Chronic Diseases, Metabolism & Ageing, KU Leuven, Leuven, Belgium.
Cognitive and Affective Neuroscience Lab (CANlab), Department of Psychological & Brain Sciences, Dartmouth College, Hanover, NH, USA.

Bettina K Wölnerhanssen (BK)

St. Clara Research Ltd at St. Clara Hospital, Basel, Switzerland.
Department of Medicine, University of Basel, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH